ALS: Klinische Studien

Schon mal daran gedacht, an einer klinischen Studie teilzunehmen und so der medizinischen Forschung zu fördern?

Was Sie über die Teilnahme an einer klinischen Studie wissen sollten? - Klicken Sie hier

Der Nutzen von Teilnahme an klinischen Studien - Klicken Sie hier

PRODUCT STUDIE STATUS END DATE RESPONSIBLE FIRM, UNIV, CLINIC OR COUNTRY
AMX-0035 PHOENIX Active Not Recruiting 03/2024 Amylyx

Antiretroviral

X Recruiting 02/2023 NINDS, Australia

Autologe Stamcellen

X Recruiting   US, Korea

Allogene Stamcellen

X     Caribbean, universities
AP101-02   Recruiting 01/2025 AL-S Pharma
BIIB105 ALSpire Recruiting 07/2026 Biogen/Ionis
Cannabinoids EMERALD Active Not Recruiting 01/2024 Australia
CU(II)ATSM   Active Not Recruiting 12/2022 Coll Med Dev Australia
Dazucorilant DAZALS Recruiting 06/2024 Corcept Therapeutics
Deferiprone FAIR-ALS II Recruiting 04/2022 France 
Edaravone oral, FAB122 ADORE Active Not Recruiting 06/2024 Mitsubishi, Ferrer
Fasudil ROCK REAL Active Not Recruiting 11/2023 Germany, France, US
GDNF   Recruiting 09/2023 Cedars Sinai
Healey Platform Trial HEALEY Recruiting   NEALS
Ibudilast (MN-166) COMBAT-ALS Recruiting 12/2024 MediciNova
ION363 fus FUSION Recruiting 03/2024 Ionis
Lithium Magnet MAGNET Recruiting   Tricals
Masinitib   Recruiting 12/2023 AB Science
Memantine and Trazodone SMART Recruiting 12/2026 UK
Presymptomatic sod1 ATLAS Recruiting 08/2027 ...

Biogen

Q-cells

ALTA BOLT Not Yet Recruiting 12/2024 Q Therapeutics
Rapamycin MONEPANTEL Active Not Recruiting 05/2023 Univ Modena
RNS60   Not Yet Recruiting 06/2024 Italy and US
SAR443820 HIMALAYA Active Not Recruiting 04/2024 Sanofi
BIIB067 Long Term sod1   Active Not Recruiting 06/2024 Biogen/Ionis
TPN-101 C9 Transposon Recruiting 03/2025 Transposon
TUDCA TUDCA-ALS OLE Active Not Recruiting 12/2022 horizon 2020
Share